Assessment and Treatment of Social Skills Deficits in Individuals With Social Phobia

NCT ID: NCT00073333

Last Updated: 2013-07-18

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

379 participants

Study Classification

INTERVENTIONAL

Study Start Date

2002-12-31

Study Completion Date

2008-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will determine whether people with social phobia are deficient in certain social skills.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Social phobia is a debilitating condition that can cause severe social, emotional, educational, and occupational functioning problems. Evidence suggests that individuals with social phobia are deficient in social skills, but the exact skills deficits have not been elucidated. This study will comprise two substudies: one will examine social skills deficits in social phobics and determine how they differ from those of people without social phobia; the other will determine if skills deficits in social phobics can be improved and whether improvements will affect overall social functioning.

Participants in this study will be randomly assigned to one of three groups for 16 weeks: an exposure group, a social skills training and exposure (SET) group, or a wait-list control group. Interviews, self-reports, and simulated role plays will be used to assess the social skills of participants.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Social Phobia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Social skills training and exposure

Group Type ACTIVE_COMPARATOR

Social Skills Training

Intervention Type BEHAVIORAL

Social skills training once per week

2

Exposure treatment

Group Type ACTIVE_COMPARATOR

Exposure Treatment

Intervention Type BEHAVIORAL

Exposure once per week

3

Placebo

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type BEHAVIORAL

Placebo

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Social Skills Training

Social skills training once per week

Intervention Type BEHAVIORAL

Exposure Treatment

Exposure once per week

Intervention Type BEHAVIORAL

Placebo

Placebo

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosis of Social Phobia

Exclusion Criteria

* Axis II diagnosis of schizoid or schizotypal personality disorder or paranoia
* Axis II diagnosis of mental retardation, obsessive-compulsive disorder, and personality disorders, except for avoidant personality disorder
* Instability on any antidepressants
* Psychotic disorder
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institute of Mental Health (NIMH)

NIH

Sponsor Role collaborator

Milton S. Hershey Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Deborah C. Beidel

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Penn State Milton S. Hershey Medical Center

Hershey, Pennsylvania, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R01MH062547

Identifier Type: NIH

Identifier Source: secondary_id

View Link

R01MH062547

Identifier Type: NIH

Identifier Source: org_study_id

View Link

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Treatment for Specific Phobias in Children
NCT00051220 COMPLETED PHASE1/PHASE2
Glucocorticoid Treatment for Social Phobia
NCT01574014 TERMINATED PHASE2
Treatment of Childhood Social Phobia
NCT00043537 COMPLETED PHASE3
Cannabidiol Effects on Fear Extinction in Social Phobia
NCT06123702 NOT_YET_RECRUITING EARLY_PHASE1